PATENT CLAIM ANALYSIS

Application Number: 15981642
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "009600"]

Abstract:
Compositions and methods are provided for the generation or treatment of chronic tympanic membrane perforation by modulation of HB-EGF activity.

Claim (Index 7):
The method of  claim 1 , wherein the formulation is provided as an aqueous solution, a gel, a lotion, a balm, paste or other vehicle.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.05
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14583708', '14131710', '14745160', '10237144', '11947952']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7340021936015498
- 35 USC 102 Novelty (BERT): 0.4951641485197122
- Combined Prediction Score: 0.7101183890933661
- Mean Citation Score: 181.872208
- Max Citation Score: 208.9095
- Similarity Product: 144.85602215901017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test